POST-MARKETING SURVEILLANCE OF MEDICINES IN THE UK

被引：0
|
作者：
GRIFFIN, JP
BAKER, R
机构：
来源：
PHARMACY INTERNATIONAL | 1981年 / 2卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：203 / 209
页数：7
相关论文
共 50 条
  • [31] POST-MARKETING DRUG SURVEILLANCE - COMPARISON OF METHODS
    REMINGTON, RD
    [J]. AMERICAN JOURNAL OF PHARMACY, 1978, 150 (03): : 72 - 80
  • [32] Post-marketing surveillance of the safety of levofloxacin in Japan
    Yamaguchi, Hiroki
    Kawai, Hitomi
    Matsumoto, Takuyuki
    Yokoyama, Hiroo
    Nakayasu, Toshio
    Komiya, Masahiro
    Shimada, Jingoro
    [J]. CHEMOTHERAPY, 2007, 53 (02) : 85 - 103
  • [33] POST-MARKETING SURVEILLANCE - HOW MANY PATIENTS
    LEWIS, JA
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1981, 2 (04) : 93 - 94
  • [34] The need for a post-marketing surveillance program in Israel
    Shemer, J
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 1999, 1 (02): : 98 - 99
  • [35] POST-MARKETING SURVEILLANCE OF ADVERSE DRUG EXPERIENCES
    CAPPUCCI, DR
    TURNER, NJ
    KLINCK, PC
    BEAULIEU, AJ
    GRAVES, WL
    [J]. JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1981, 179 (03) : 264 - 264
  • [36] Post-marketing surveillance of modafinil abuse and misuse
    Smith, DE
    Calhoun, SR
    Galloway, GP
    Romanoff, SJ
    Wolfe, NE
    [J]. SLEEP, 2004, 27 : 57 - 57
  • [37] RESULTS OF POST-MARKETING SURVEILLANCE PROGRAM ON STREPTOKINASE
    THAYER, CF
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1981, 30 (01): : 129 - 140
  • [38] Post-marketing surveillance and adverse drug reactions
    Shani, S
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 1999, 1 (02): : 117 - 119
  • [39] Post-marketing surveillance of levofloxacin checks out
    [J]. Reactions Weekly, 2007, 1149 (1) : 4 - 4
  • [40] Signal detection in post-marketing surveillance for controlled substances
    Dasgupta, Nabarun
    Schnoll, Sidney H.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2009, 105 : S33 - S41
12345